Related references
Note: Only part of the references are listed.Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis
Aurelien Delluc et al.
HAEMATOLOGICA (2020)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer-A Retrospective Analysis
Joao Godinho et al.
ONCOLOGIST (2020)
The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma
Onur Kirkizlar et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D-Dimer analysis: A prospective study
Florian Posch et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
External Validation of a Venous Thromboembolic Risk Score for Cancer Outpatients with Solid Tumors: The COMPASS-CAT Venous Thromboembolism Risk Assessment Model
Alex C. Spyropoulos et al.
ONCOLOGIST (2020)
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
Frits Mulder et al.
BLOOD (2020)
Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients
Marcello Di Nisio et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
A. A. Khorana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge et al.
LANCET ONCOLOGY (2019)
The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
Frits I. Mulder et al.
HAEMATOLOGICA (2019)
A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study
Annatina Schnegg-Kaufmann et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Frequency of arterial thromboembolism in populations with malignancies: A systematic review
James Yu (Tian) Wei et al.
THROMBOSIS RESEARCH (2019)
The risk of arterial thromboembolic events after cancer diagnosis
Babak B. Navi et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)
Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer
Andres J. Munoz Martin et al.
BRITISH JOURNAL OF CANCER (2018)
Frequency, risk actors, and impact on mortality of arterial thromboembolism in patients with cancer
Ella Grilz et al.
HAEMATOLOGICA (2018)
Genes associated with venous thromboembolism in colorectal cancer patients
B. Unlu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study
P. . W. Kamphuisen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients
Joanna Rupa-Matysek et al.
MEDICAL ONCOLOGY (2018)
What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients' Quality of Life?
Andrew J. Lloyd et al.
VALUE IN HEALTH (2018)
Frequency, risk actors, and impact on mortality of arterial thromboembolism in patients with cancer
Ella Grilz et al.
HAEMATOLOGICA (2018)
Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment
Joshua D. Brown et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice
Joanna Rupa-Matysek et al.
CANCER MEDICINE (2018)
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
Ingrid Pabinger et al.
LANCET HAEMATOLOGY (2018)
Artificial intelligence for cancer-associated thrombosis risk assessment
Patrizia Ferroni et al.
LANCET HAEMATOLOGY (2018)
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study
Nick van Es et al.
HAEMATOLOGICA (2017)
Discrimination and Calibration of Clinical Prediction Models Users' Guides to the Medical Literature
Ana Carolina Alba et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study
Chiara Alessandra Cella et al.
ONCOLOGIST (2017)
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study
Grigoris T. Gerotziafas et al.
ONCOLOGIST (2017)
Cancer-associated venous thromboembolism: Burden, mechanisms, and management
Cihan Ay et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study
Nick van Es et al.
HAEMATOLOGICA (2017)
Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients
Darko Antic et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Hypercoagulabilty, venous thromboembolism, and death in patients with cancer A Multi-State Model
Florian Posch et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Epidemiology of cancer-associated venous thrombosis
Jasmijn F. Timp et al.
BLOOD (2013)
Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?
U. Pelzer et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2013)
Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States
Alok A. Khorana et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2013)
Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism
Martha L. Louzada et al.
CIRCULATION (2012)
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
Melina Verso et al.
INTERNAL AND EMERGENCY MEDICINE (2012)
Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
Freesia Horsted et al.
PLOS MEDICINE (2012)
Prediction of venous thromboembolism in cancer patients
Cihan Ay et al.
BLOOD (2010)
Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
Toni K. Choueiri et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism.: Findings from the RIETE Registry
Nuria Ruiz-Gimenez et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Predicting recurrences or major bleeding in cancer patients with venous thromboembolism - Findings from the RIETE Registry
Javier Trujillo-Santos et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab
FA Scappaticci et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
P Prandoni et al.
BLOOD (2002)
Prognosis of cancers associated with venous thromboembolism.
HT Sorensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
